Accutane: The Basics By Dr. David Robles MD, PhD, Jacob Anderson, B.S, and Anais Hacobian, B.S.


What is Isotretinoin? 
(aka Accutane) 

Isotretinoin is considered the most effective and powerful acne treatment available. It helps eliminate acne and also significantly improves the texture of the skin and improves acne scarring. The drug is classified as a retinoid (a Vitamin A derivative), that is capable of regulating epithelial cell growth.

Isotretinoin is more commonly known as “Accutane”. Unlike other acne treatments, isotretinoin is an oral medication that is taken daily for a span of 4 to 6 months (dosage varies based on weight and acne severity). The goal of taking isotretinoin is to clear one’s acne and to produce permanent acne relief. See below for before and after treatment. 









How does Isotretinoin work?

Isotretinoin works by decreasing the size of the sebaceous glands, which secrete oil (sebum). Decreasing the size and production of these glands also reduces the number of bacteria in the follicles. In most cases, isotretinoin provides prolonged clearance and sometimes effectively cures one of their acne. In a subset of patients, particularly those with extensive acne, the acne can return over time and may require a second round of treatment. 


What are the side effects of Isotretinoin? 

The most common side effect of isotretinoin is dry, chapped lips. This is easily treated with frequent application of Vaseline or Aquaphor ointment. Some patients also experience dry skin and dry eyes, which can be improved with moisturizing cream and artificial tears. Some people may feel more sensitive in the sun and sunscreen should be used when outdoors. 

A subset of patients may experience nose bleeds due to the dryness of the skin in the nasal mucosa. For those individuals, we recommend the use of saline nasal sprays. In eczema-prone patients, the dry skin may precipitate an eczema-like reaction, which is easily controlled with prescription cortisone creams and moisturizing creams. Most patients show improvement in their acne in the first month, but a subset of patients may get a little worse before they get better. All other potential side effects are much less common.  

IMPORTANT FOR WOMEN

Isotretinoin must be taken with caution in females, because if taken while pregnant, it can cause significant fetal abnormalities. In order to prevent birth defects from occurring, isotretinoin is monitored through a system called “iPledge”, which is a personal agreement to not get pregnant while on the medication. Due to the fetal risk, people on isotretinoin should not donate blood during the course of treatment and for 30 days after the last dose. 

Before starting isotretinoin, patients must register with the iPledge system; females will have a 30 day waiting period after registering while males can start immediately after registration. The reason for the 30 day waiting period in females is to have two negative pregnancy tests documented and it gives those in need of contraception the chance to get started on it so that it's effective by the time they start isotretinoin. Only women who are incapable of having children (e.g., hysterectomy or menopause) do not have to wait 30 days.  

Once the medication is started, patients must follow up every 4 weeks in order to receive a refill. The 4 week follow-up is to check how patients are handling the medication and to address any possible side effects. For females, the follow-up also includes the verification of a negative pregnancy test.

Women of reproductive age who are sexually active are required to be on two forms of birth control, for example, the contraceptive pill and condoms. It is important to note that isotretinoin does not affect a woman's ability to have healthy babies in the future, nor does it affect her fertility. 

Is drug monitoring required? 

Monthly lab assessments used to be a routine part of isotretinoin treatment; however, there is evidence that this intensive blood monitoring is not necessary. Many experts recommend a baseline blood test and again after two months of treatment. Laboratory abnormalities if present are often short-lived and normalize following discontinuance of isotretinoin. 
 
Is Isotretinoin linked to depression? 

Most well controlled studies have concluded that there is no definitive causal link between isotretinoin and depression. Two recent studies published in February and March of 2021, concluded that patients on isotretinoin were actually less likely to engage in suicidal behavior and experience less psychological distress and depressive symptoms compared to controls. Another study conducted in 2019 links the use of isotretinoin to an improvement in psychological well-being, even in patients suffering from an underlying mental illness. Nevertheless, anyone experiencing any symptoms of a declined psychological state or depression while on isotretinoin should speak to their dermatologist immediately. 

Is Isotretinoin linked to Crohn’s disease? 

Most studies show that exposure to isotretinoin is not associated with an increased risk of developing both Ulcerative colitis and Crohn’s disease, and may even be associated with a decreased risk. 

See Additional Literature: 
(Click on blue links for article)

 

Isotretinion and Depression

Acne Drug Accutane May Not Depress Mood After All

Conclusions: "Our retrospective, population-based study shows no increased risk of depression in patients taking isotretinoin, compared to patients with acne but not taking isotretinoin"


Does isotretinoin cause depression and anxiety in acne patients?

Conclusions: Although the psychiatrists are concerned about the potential psychiatric side effects of isotretinoin, our data support no causal relationship between isotretinoin use and depression in acne patients.


Depression is not common in isotretinoin-treated acne patients

Suicide, depression, and isotretinoin: is there a causal link?

Conclusions: Based on this review, the authors conclude that there is no evidence to support a causal connection between isotretinoin and major depression or suicide


Is there an association between isotretinoin therapy and adverse mood changes? A prospective study in a cohort of acne patients


Conclusions: The relationship between isotretinoin and depression is the most debated aspect of isotretinoin therapy. Our results link isotretinoin to an overall improvement in psychological wellbeing, even in patients suffering with stable mental illness.



Isotretinoin, depression and suicide: a review of the evidence


Conclusions: While isotretinoin, used to treat acne vulgaris, has not been demonstrated to be associated with depression or suicide, the possibility of a relatively rare idiosyncratic adverse effect remains. 


Mood changes, depression and suicide risk during isotretinoin treatment: a prospective study

Conclusions: We did not find any depressive symptoms or suicide risk caused by isotretinoin. On the contrary, a statistically significant improvement of BDI-II scores was found.


No association found between patients receiving isotretinoin for acne and the development of depression in a Canadian prospective cohort

Conclusions: Isotretinoin does not appear to be associated with the development of depression. Thus, denying patients with significant acne an effective medication for fear of developing depression may not be indicated at this point in time.


Isotretinoin and the controversy of psychiatric adverse effects

Conclusions: Although a variety of anecdotal and epidemiologic studies are available, the overall lack of concrete scientific data limits any conclusion that can be drawn about a causal relationship between istotretinoin and psychiatric adverse events. 


Psychological impact of isotretinoin treatment in patients with moderate and severe acne

Conclusions: The results of this study do not find a significant correlation between the use of isotretinoin and the psychological effects of the drug.


Isotretinoin treatment for acne and risk of depression: A systematic review and meta-analysis

Conclusions: Isotretinoin treatment for acne does not appear to be associated with an increased risk for depression. Moreover, the treatment of acne appears to ameliorate depressive symptoms.


Use of isotretinoin and risk of depression in patients with acne: a systematic review and meta-analysis

Conclusions: This study suggested an association of the use of isotretinoin in patients with acne with significantly improved depression symptoms.


Comparison of Quality of Life, Depression, Anxiety, Suicide, Social Anxiety and Obsessive-Compulsive Symptoms Between Adolescents with Acne Receiving Isotretinoin and Antibiotics: A Prospective, Non-randomised, Open-Label Study

Conclusions: We found that neither isotretinoin nor antibiotic treatment affected the levels of depression, anxiety, and suicide in acne patients. Moreover, both isotretinoin and antibiotic treatment were shown to improve the quality of life, social anxiety, and obsessive-compulsive symptoms in acne patients.


Differences in Depression and Distress Between Acne Patients on Isotretinoin vs Oral Antibiotics


Conclusions: Acne patients on isotretinoin experienced less depressive symptoms and psychological distress as compared to oral antibiotics


Evaluating Depression Among Acne Vulgaris Patients Treated With Isotretinoin

Conclusions: The results of this study did not reveal a direct relationship between the use of isotretinoin and the development of depression. Furthermore, optimum control and treatment of acne vulgaris have shown to improve depression scores.


Consensus on the use of oral isotretinoin in dermatology - Brazilian Society of Dermatology

Conclusions: Common and manageable common adverse events are mucocutaneous in nature. Others, such as growth retardation, abnormal healing, depression, and inflammatory bowel disease have been thoroughly investigated, and there is no evidence of a causal association


                   Lab Monitoring


Laboratory Monitoring During Isotretinoin Therapy for Acne: A Systematic Review and Meta-analysis

Conclusions: The evidence from this study does not support monthly laboratory testing for use of standard doses of oral isotretinoin for the standard patient with acne.


The clinical utility of laboratory monitoring during isotretinoin therapy for acne and changes to monitoring practices over time

Conclusions: There are opportunities to improve the quality of care among patients being treated with isotretinoin for acne by reducing the frequency of lipid and liver function monitoring and by eliminating complete blood count monitoring.


Minimize the regular laboratory monitoring during the systemic isotretinoin treatment: data of 704 patients with acne vulgaris


Conclusions: Clinically insignificant and reversible CBC abnormalities, mild to moderate elevation of liver transaminases and serum lipids are the most common laboratory abnormalities in patients with acne treated with oral isotretinoin. Due to these abnormalities are reversible even the isotretinoin therapy continued, and generally there is no need to discontinuation of treatment due to laboratory abnormalities, frequent biochemical monitoring is not recommended.


A Population-Based Analysis of Laboratory Abnormalities During Isotretinoin Therapy for Acne Vulgaris


Conclusions: Routine monitoring of white blood cell count, hemoglobin level, and platelet count during isotretinoin therapy may be of little utility without clinical suspicion of an abnormality.


Isotretinion and Inflammatory 

Bowel Disease


Isotretinoin exposure and risk of inflammatory bowel disease

Conclusions: Our study did not show an increased risk of IBD with prior isotretinoin use. If anything, the risk seemed to be decreased. Although these results may be due to chance given the small number of IBD cases, the anti-inflammatory and immune-modulating effects of isotretinoin may be worth exploring.


Isotretinoin and risk of inflammatory bowel disease: a French nationwide study

Conclusions: In this population-based case-control study, isotretinoin use was not associated with increased UC risk but was associated with a decreased CD risk. This study provides reassuring data for people using isotretinoin.


Does exposure to isotretinoin increase the risk for the development of inflammatory bowel disease? A meta-analysis

Conclusions: Isotretinoin exposure is not associated with an increased risk of developing both ulcerative colitis and Crohn's disease.


Risk of new-onset inflammatory bowel disease among patients with acne vulgaris exposed to isotretinoin

Conclusions: IBD incidence among isotretinoin-exposed patients with Acne Vulgaris is very low, and the risk appears similar to that for unexposed patients with Acne Vulgaris.